+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Abdominal lymph node metastasis in patients with non-small-cell lung cancer as shown by PET/CT



Abdominal lymph node metastasis in patients with non-small-cell lung cancer as shown by PET/CT



Clinical Nuclear Medicine 38(9): 691-694



The aim of this study is to investigate the frequency and the spread of abdominal lymph node metastasis in patients with non-small-cell lung cancer (NSCLC) by (18)F-FDG PET/CT. Retrospective evaluation of the (18)F-FDG PET/CT examinations of 1191 patients diagnosed with NSCLC was performed. The metastatic abdominal lymph nodes of the patients were classified as inside the routine imaging field (covering the field of chest CT including adrenal glands) and outside the field. Seventy-four patients (6 F, 68 M; mean: 61 ± 11 years old) among 1191 patients (6%) were identified to have abdominal lymph node metastases. These abdominal lymph node metastasis changed management in 10 out of 74 patients (14%), and there were lymph node metastases outside the routine conventional imaging field in 43 (58%) patients. (18)F-FDG PET/CT provided identification of the distant metastatic lymph nodes out of conventional imaging field in more than half of NSCLC patients with abdominal metastasis which changed patient management in 14% of the patients due to abdominal lymph node metastasis outside the routine imaging field. This study shows the necessity of imaging NSCLC patients with an imaging protocol with larger imaging field like PET/CT.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051302589

Download citation: RISBibTeXText

PMID: 23816947

DOI: 10.1097/rlu.0b013e31829b9bed


Related references

Advances of mediastinal lymph node metastasis and the extent of lymph node 
dissection in patients with stage T1 non-small cell lung cancer. Zhongguo Fei Ai Za Zhi 18(1): 34-41, 2015

Exploration of lymph node metastasis and appropriate lymph node dissection modes in patients with clinical stage I non-small cell lung cancer. Zhonghua Zhong Liu Za Zhi 36(7): 536-540, 2014

Necessity of preoperative screening for brain metastasis in non-small cell lung cancer patients without lymph node metastasis. Annals of Thoracic and Cardiovascular Surgery 10(6): 347-349, 2004

MiR-339-5p inhibits cell migration and invasion in vitro and may be associated with the tumor-node-metastasis staging and lymph node metastasis of non-small cell lung cancer. Oncology Letters 8(2): 719-725, 2014

Predictors of lymph node metastasis and possible selective lymph node dissection in clinical stage IA non-small cell lung cancer. Journal of Thoracic Disease 10(7): 4061-4068, 2018

Predictive risk factors for lymph node metastasis in patients with small size non-small cell lung cancer. Journal of Thoracic Disease 6(12): 1697-1703, 2014

Diagnostic value of dual energy CT for lymph node metastasis in patients with non-small cell lung cancer. Zhejiang Da Xue Xue Bao. Yi Xue Ban 46(5): 511-516, 2017

P3.16-002 Postoperative Prognostic Factors in Non-Small Cell Lung Cancer Patients with Lymph Node Metastasis. Journal of Thoracic Oncology 12(11): S2343-S2344, 2017

Expression of nestin in lymph node metastasis and lymphangiogenesis in non-small cell lung cancer patients. Human Pathology 41(5): 737-744, 2010

Is Topographic Classification Effective for Lymph Node Metastasis in Patients Affected by Non-Small Cell Lung Cancer?. Chest 152(6): 1354-1355, 2017

Synaptonemal complex protein 3 is associated with lymphangiogenesis in non-small cell lung cancer patients with lymph node metastasis. Journal of Translational Medicine 15(1): 138, 2017

Dual-time-point FDG-PET for evaluation of lymph node metastasis in patients with non-small-cell lung cancer. Annals of Nuclear Medicine 22(4): 245-250, 2008

Is Topographic Classification Effective for Lymph Node Metastasis in Patients Affected by Non-Small Cell Lung Cancer?. Chest Journal 152(6): 1354-1355, 2017

The incidence of lymph node metastasis in patients with different oncogenic driver mutations among T1 non-small-cell lung cancer. Lung Cancer 134: 218-224, 2019

Overexpression of SCC-S2 correlates with lymph node metastasis and poor prognosis in patients with non-small-cell lung cancer. Cancer Science 101(6): 1562-1569, 2010